Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

fostamatinib disodium

(FOS-tuh-MA-tih-nib dy-SOH-dee-um)
A drug used to treat thrombocytopenia (a low blood platelet count) in adults with chronic immune thrombocytopenia (ITP) that did not get better with other treatment. ITP is a condition in which platelets are destroyed by the immune system. Fostamatinib disodium is also being studied in the treatment of other conditions and types of cancer. It blocks an enzyme called Syk, which may help keep the immune system from destroying platelets. Fostamatinib disodium is a type of tyrosine kinase inhibitor. Also called R788 sodium, Syk kinase inhibitor R-935788, and Tavalisse.
Search NCI's Dictionary of Cancer Terms